Trump's Budget Blueprint: Cosmetics Opportunity Or Unhelpful Distraction?
This article was originally published in The Rose Sheet
Executive Summary
President Trump appears to want greater user-fee contributions from FDA-regulated industries to offset cuts to federal spending in fiscal 2018. His recently released budget blueprint could complicate negotiations that cosmetics stakeholders were hoping to join, but it also could signal opportunity for an industry seeking increased regulation – and willing to pay for it.